Eden Research Share Discussion Threads

[neutralpov] 01/4/2021 11:54

ravenna23 1 Apr '21 - 08:54 - 9050
> the price is headed back to 5p. ;(

Please cut back on the ramping. ;)
The target is 0p.

[investingisatrickygame] 01/4/2021 10:43

Rav

"If they were awarded a deal completion bonus I wouldn’t have a problem". I'm in agreement with that, much better alignment.

[supersonico] 01/4/2021 09:47

Rav,

And your surprised??

That's the way it's always been here.

Swizz knows that.

NeutralPOV25 Jun '21 - 16:28 - 9865 of 9865
0 0 0
Hint For Stupids

The biopharma field is overcrowded even among tech corps.

[ravenna23] 01/4/2021 09:43

Investing, we will have to agree to disagree on this one. The optics are all wrong. If they were awarded a deal completion bonus I wouldn't have a problem. However this demonstrates that the company is being run in the best interest of executives and not shareholders. Interests are misaligned.

[weyweyumfozo] 01/4/2021 09:43

Surely if this was announced in the Company's fundraising on 28 February 2020, it's old news?

The share price was about 8p at the time.

[erinvale1] 01/4/2021 09:42

Investing / Quazie: you make a good point. It would give greater confidence to the market if the options were not already in massive profit, should Smith and Abrey sell today. Options in these circumstances, should be tailored to reflect future performance not to reward what many (including me) see as lack of it.

Investing: if Eden has such important and world-beating IP (which I believe it does), big agri should be beating a path to its new office door to strike a deal. There isn't any evidence of this that I can see. Eden should be negotating from a position of strength, not of supplication.

[supersonico] 01/4/2021 09:34

quazie12 10 Feb '21 - 09:41 - 8814 of 8815
0 1 0
Maybe let Investing answer questions himself in future I’m sure he is a big boy. You need to maybe broaden your investment horizons, it will make you less twisted.

Anyways no need to worry, I wont be back here. I hope that the fortunes of Eden have turned a corner and I wish investors well.

.........................

'I wont be back here'.

[quazie12] 01/4/2021 09:34

These options are in the money to the tune of 10p each so 10.5m is £1,050,000. Market cap of £58m at today's share price so isnt that an instant 1.81% dilution at the stroke of an RNS to every single shareholder of the company ?

[quazie12] 01/4/2021 09:29

Takes a big leap of faith to correlate the executives announcing they are taking yet another slice of shareholder value from you and awarding it to themselves into a sign of great deals about to be announced. A 6p strike price is outrageous and reflects the corporate greed on display. Reward for abject performance indeed.

[quazie12] 01/4/2021 09:25

Why not discuss/debate the recent Executive Share Options RNS on here instead ?

[quazie12] 01/4/2021 09:23

Supersonic you really are childish. Grow up ffs.

[investingisatrickygame] 01/4/2021 09:21

ravenna,

sadly, it occurs all the time. That is not to say the execs haven't worked exceptionally hard to get to this point and this rewards that. It cannot be easy for minnow Eden to strike what will be a long term recurring income with one of the world's major crop science companies and they will deserve proper credit for that if we get the resulting RNS. I think we will based on the timing of today's RNS.

It is fair to say they already earn a lot of money. I would have preferred to see the exercise price staggered, so maybe some at 10p and some at 50p and more. Why not given the game-changer that Corteva might be. It would send a better signal to the market. That said, it was set out in the Placing RNS and you and I have no comeback against 'Remuneration Committee's'. That is a point that AIM should regulate.

I remain confident that Corteva will be delivered and a host of regulatory approvals will now filter through delivering even greater annual revenue and profits.

[ravenna23] 01/4/2021 09:14

Investing, if the share price is going to rocket how can the execs justify such a low strike price. There is no real incentive to perform if you are given money for nothing. Perhaps they are spending time discussing how to invest in a brace of Astons at shareholder expense. After all they have delivered astonishing value so far.

[investingisatrickygame] 01/4/2021 09:05

Pending potential business values as declared by Eden through various RNS

Per annum

Corteva €40 million
Insecticides €85 million
Cedroz and Mevalone €330 million

€455 in total. If Eden delivers part of that the share price rockets.

[supersonico] 01/4/2021 07:51

quazie12 10 Feb '21 - 09:41 - 8814 of 8815
0 1 0
Maybe let Investing answer questions himself in future I’m sure he is a big boy. You need to maybe broaden your investment horizons, it will make you less twisted.

Anyways no need to worry, I wont be back here. I hope that the fortunes of Eden have turned a corner and I wish investors well.

[quazie12] 01/4/2021 07:46

Nah unfortunately she was quoting me from February. Never figured out the agenda but the time invested in Eden bulletin board over many years is extraordinary.At the current market cap the BoD have just diluted you unsuspecting shareholders by another 2%

[erinvale1] 01/4/2021 07:40

Smith and Abrey already have substantial options. I do not see the need to further reward them for a job they should be doing anyway.

[ravenna23] 01/4/2021 07:35

So SuperSonico, you think it is OK to give free money to executives who are already being paid extremely well to do their job. The strike price of 6p is ludicrous. 60% below current market price. If top shareholders have approved this because they know the deal is about to be inked that speaks of corruption at the top of the company. Cronyism at its worst, and UK business practice at its least ethical.

[supersonico] 01/4/2021 07:25

Erinvale

Personally I don't think they are rewarding failure..my guess is they are rewarding a potentially massive deal which to date we are in the dark about..but I'm confident it's coming. That's what LuckyRobs Bayer folk are signalling imo.

[erinvale1] 01/4/2021 07:18

RNS today: In the announcement of the Company's fundraising on 28 February 2020, the Company stated that it would implement a new Long-Term Incentive Plan (LTIP) and replace options granted under the previous LTIP that are deemed a more appropriate scheme to incentivise management given the Company's stage of development. In line with that announcement, the Company has now granted replacement options over 10.5 million new Ordinary Shares in Eden, at a strike price of 6p each (being the placing price of the 2020 fundraise), in the amounts of 6 million awarded to Sean Smith and 4.5 million awarded to Alex Abrey.

Why on earth is this company rewarding failure. This effectively gives Smith and Abrey an instant profit of 9p per share. THis is a smack in the face for shareholders in the face of serial management failure to achieve sales and take the company into profit.

I notice, Supersonico, that you signalled that you were off this thread!

[supersonico] 01/4/2021 07:15

LuckyRob (+2) Bayer folk who appreciate 'Eden Research partner gets the green light in Spain for bio-fungicide' post on Linked-in.

As one who follows the story ( not the Unmentionable story the other one)I used to think that Tara Lu might have been a old mate of Robs who happened to be involved with Bayer in Biologicals and Biopesticide patents and that she followed his career closely.



Methods of inhibiting, preventing, killing and/or repelling insects using simulated blends of chenopodium


But then Wolfgang-Korzeniewski who has a nice job as Bayer's 'Strategy development for multinational production networks' has started liking Eden Linked-in posts..Maybe he's a mate or friend of Shortorder?or just a keen to help Eden become a 'Consolidator'.




But then maybe another friend of Rob who is kindly supportive pops up occasionally who has a Bayer Seed job as 'EMEA Business Portfolio Manager, Oilseed Rape Seeds at Bayer Crop Science'



All I can say is lucky Rob having all these nice Bayer friends closely following his career so attentively and especially since Eden have no declared relationship with Bayer Crop Science.

And there's more ..senior Bayer mates are coming out of the wood work..

Swantje Behnken
Head of Target Biology bei Bayer Crop Science




Michael Klueken
Project Development Manager bei Bayer Crop Science